Glenn-Milo Santos1, Nneka I Emenyonu2, Francis Bajunirwe3, A Rain Mocello2, Jeffrey N Martin2, Eric Vittinghoff2, David R Bangsberg4, Judith A Hahn5. 1. University of California, San Francisco, United States; San Francisco Department of Public Health, United States. 2. University of California, San Francisco, United States. 3. Mbarara University of Science and Technology, Uganda. 4. Massachusetts General Hospital, United States. 5. University of California, San Francisco, United States. Electronic address: Judy.hahn@ucsf.edu.
Abstract
BACKGROUND: There is limited data on the impact of anti-retroviral treatment (ART) initiation on alcohol consumption. We characterized predictors of abstaining from alcohol among HIV-infected individuals following ART initiation. METHODS: We analyzed data from a prospective cohort of HIV-infected adults in Mbarara, Uganda with quarterly measures of self-reported alcohol consumption, socio-demographics, health status, and blood draws. We used pooled logistic regression to evaluate predictors of becoming abstinent from alcohol for at least 90 days after baseline. RESULTS: Among the 502 participants, 108 (21.5%) were current drinkers who consumed alcohol within 90 days of baseline, 206 (41.0%) were former drinkers, and 188 (37.5%) were lifetime abstainers at baseline. Among current drinkers, 67 (62.0%) drank at hazardous levels. 90 of current drinkers (83.3%) abstained from alcohol at least for 90 days over 3.6 median years of follow-up [IQR 2-4.8]; of those 69 (76.7%) remained abstinent for a median duration of follow-up of 3.25 years [1.6-4.5]. Becoming abstinent was independently associated with lower baseline AUDIT score (adjusted odds ratio [AOR] 0.95 [95%CI 0.91-0.99]), baseline physical health score (AOR 0.92 [0.87-0.97]), and decreases in physical health score at follow-up visits (AOR 0.92 [0.88-0.97)). Alcohol abstinence was most likely to start immediately after ART initiation (AORs for 6 month versus 3 month visit: 0.25 [0.10-0.61]; 9 month visit or later versus 3 month visit: 0.04 [0.02-0.09]). CONCLUSIONS: We found that a large majority of drinkers starting ART reported that they became and remained abstinent from alcohol. ART initiation may be an opportune time to implement interventions for alcohol consumption and other health behaviors.
BACKGROUND: There is limited data on the impact of anti-retroviral treatment (ART) initiation on alcohol consumption. We characterized predictors of abstaining from alcohol among HIV-infected individuals following ART initiation. METHODS: We analyzed data from a prospective cohort of HIV-infected adults in Mbarara, Uganda with quarterly measures of self-reported alcohol consumption, socio-demographics, health status, and blood draws. We used pooled logistic regression to evaluate predictors of becoming abstinent from alcohol for at least 90 days after baseline. RESULTS: Among the 502 participants, 108 (21.5%) were current drinkers who consumed alcohol within 90 days of baseline, 206 (41.0%) were former drinkers, and 188 (37.5%) were lifetime abstainers at baseline. Among current drinkers, 67 (62.0%) drank at hazardous levels. 90 of current drinkers (83.3%) abstained from alcohol at least for 90 days over 3.6 median years of follow-up [IQR 2-4.8]; of those 69 (76.7%) remained abstinent for a median duration of follow-up of 3.25 years [1.6-4.5]. Becoming abstinent was independently associated with lower baseline AUDIT score (adjusted odds ratio [AOR] 0.95 [95%CI 0.91-0.99]), baseline physical health score (AOR 0.92 [0.87-0.97]), and decreases in physical health score at follow-up visits (AOR 0.92 [0.88-0.97)). Alcohol abstinence was most likely to start immediately after ART initiation (AORs for 6 month versus 3 month visit: 0.25 [0.10-0.61]; 9 month visit or later versus 3 month visit: 0.04 [0.02-0.09]). CONCLUSIONS: We found that a large majority of drinkers starting ART reported that they became and remained abstinent from alcohol. ART initiation may be an opportune time to implement interventions for alcohol consumption and other health behaviors.
Authors: Rebecca K Papas; John E Sidle; Benson N Gakinya; Joyce B Baliddawa; Steve Martino; Michael M Mwaniki; Rogers Songole; Otieno E Omolo; Allan M Kamanda; David O Ayuku; Claris Ojwang; Willis D Owino-Ong'or; Magdalena Harrington; Kendall J Bryant; Kathleen M Carroll; Amy C Justice; Joseph W Hogan; Stephen A Maisto Journal: Addiction Date: 2011-08-18 Impact factor: 6.526
Authors: Judith A Hahn; Robin Fatch; Jane Kabami; Bernard Mayanja; Nneka I Emenyonu; Jeffrey Martin; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2012-12-01 Impact factor: 3.731
Authors: Catherine A Staton; Duan Zhao; Elizabeth E Ginalis; Jon Mark Hirshon; Francis Sakita; Monica H Swahn; Blandina Theophil Mmbaga; Joao Ricardo Nickenig Vissoci Journal: Alcohol Clin Exp Res Date: 2020-11-10 Impact factor: 3.455
Authors: Julian Adong; Christina Lindan; Robin Fatch; Nneka I Emenyonu; Winnie R Muyindike; Christine Ngabirano; Michael R Winter; Christine Lloyd-Travaglini; Jeffrey H Samet; Debbie M Cheng; Judith A Hahn Journal: AIDS Behav Date: 2018-06
Authors: Judith A Hahn; Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekiibina; Adam W Carrico; Sarah Woolf-King; Stephen Shiboski Journal: Addiction Date: 2015-11-05 Impact factor: 6.526
Authors: Panagiotis Vagenas; Marwan M Azar; Michael M Copenhaver; Sandra A Springer; Patricia E Molina; Frederick L Altice Journal: Curr HIV/AIDS Rep Date: 2015-12 Impact factor: 5.071
Authors: Francis Bajunirwe; Jessica E Haberer; Yap Boum; Peter Hunt; Rain Mocello; Jeffrey N Martin; David R Bangsberg; Judith A Hahn Journal: PLoS One Date: 2014-12-01 Impact factor: 3.240
Authors: Radhika Sundararajan; Monique A Wyatt; Sarah Woolf-King; Emily E Pisarski; Nneka Emenyonu; Winnie R Muyindike; Judith A Hahn; Norma C Ware Journal: AIDS Behav Date: 2015-04
Authors: Muhamadi Lubega; Neema Nakyaanjo; Sumaya Nansubuga; Edgar Hiire; Godfrey Kigozi; Gertrude Nakigozi; Tom Lutalo; Fred Nalugoda; David Serwadda; Ronald Gray; Maria Wawer; Caitlin Kennedy; Steven James Reynolds Journal: BMC Public Health Date: 2015-10-08 Impact factor: 3.295